Report Detail
Global SPECT Radiopharmaceuticals Market Insights, Forecast to 2025
- RnM2888615 |
- 08 March, 2019 |
- Global |
- 112 Pages |
- QYResearch |
- Pharma & Healthcare
A Single Photon Emission Computed Tomography (SPECT) scan is a type of nuclear imaging test that shows how blood flows to tissues and organs. Nuclear imaging requires small amounts of radioactive materials called radiopharmaceuticals – injected, inhaled or swallowed – to diagnose disease. SPECT radiopharmaceuticals include Tc-99m, Tl-201, Ga-67, I-123, In-111，and other SPECT isotopes.
The global SPECT Radiopharmaceuticals market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the SPECT Radiopharmaceuticals market based on company, product type, end user and key regions.
This report studies the global market size of SPECT Radiopharmaceuticals in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of SPECT Radiopharmaceuticals in these regions.
This research report categorizes the global SPECT Radiopharmaceuticals market by top players/brands, region, type and end user. This report also studies the global SPECT Radiopharmaceuticals market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
GE Healthcare
Cardinal Health
Lantheus Medical Imaging
Bracco Imaging
Eczacibasi-Monrol Nuclear Products
IBA Molecular Imaging
Jubilant Life Sciences
Market size by Product
Technetium-99
Thallium-201
Gallium-67
Iodine-123
Indium-111
Other
Market size by End User
Oncology
Cardiology
Thyroid
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global SPECT Radiopharmaceuticals market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of SPECT Radiopharmaceuticals market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global SPECT Radiopharmaceuticals companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of SPECT Radiopharmaceuticals submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of SPECT Radiopharmaceuticals are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of SPECT Radiopharmaceuticals market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 SPECT Radiopharmaceuticals Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global SPECT Radiopharmaceuticals Market Size Growth Rate by Product
- 1.4.2 Technetium-99
- 1.4.3 Thallium-201
- 1.4.4 Gallium-67
- 1.4.5 Iodine-123
- 1.4.6 Indium-111
- 1.4.7 Other
- 1.5 Market by End User
- 1.5.1 Global SPECT Radiopharmaceuticals Market Size Growth Rate by End User
- 1.5.2 Oncology
- 1.5.3 Cardiology
- 1.5.4 Thyroid
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global SPECT Radiopharmaceuticals Market Size
- 2.1.1 Global SPECT Radiopharmaceuticals Revenue 2014-2025
- 2.1.2 Global SPECT Radiopharmaceuticals Sales 2014-2025
- 2.2 SPECT Radiopharmaceuticals Growth Rate by Regions
- 2.2.1 Global SPECT Radiopharmaceuticals Sales by Regions
- 2.2.2 Global SPECT Radiopharmaceuticals Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 SPECT Radiopharmaceuticals Sales by Manufacturers
- 3.1.1 SPECT Radiopharmaceuticals Sales by Manufacturers
- 3.1.2 SPECT Radiopharmaceuticals Sales Market Share by Manufacturers
- 3.1.3 Global SPECT Radiopharmaceuticals Market Concentration Ratio (CR5 and HHI)
- 3.2 SPECT Radiopharmaceuticals Revenue by Manufacturers
- 3.2.1 SPECT Radiopharmaceuticals Revenue by Manufacturers (2014-2019)
- 3.2.2 SPECT Radiopharmaceuticals Revenue Share by Manufacturers (2014-2019)
- 3.3 SPECT Radiopharmaceuticals Price by Manufacturers
- 3.4 SPECT Radiopharmaceuticals Manufacturing Base Distribution, Product Types
- 3.4.1 SPECT Radiopharmaceuticals Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers SPECT Radiopharmaceuticals Product Type
- 3.4.3 Date of International Manufacturers Enter into SPECT Radiopharmaceuticals Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global SPECT Radiopharmaceuticals Sales by Product
- 4.2 Global SPECT Radiopharmaceuticals Revenue by Product
- 4.3 SPECT Radiopharmaceuticals Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global SPECT Radiopharmaceuticals Breakdown Data by End User
6 North America
- 6.1 North America SPECT Radiopharmaceuticals by Countries
- 6.1.1 North America SPECT Radiopharmaceuticals Sales by Countries
- 6.1.2 North America SPECT Radiopharmaceuticals Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America SPECT Radiopharmaceuticals by Product
- 6.3 North America SPECT Radiopharmaceuticals by End User
7 Europe
- 7.1 Europe SPECT Radiopharmaceuticals by Countries
- 7.1.1 Europe SPECT Radiopharmaceuticals Sales by Countries
- 7.1.2 Europe SPECT Radiopharmaceuticals Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe SPECT Radiopharmaceuticals by Product
- 7.3 Europe SPECT Radiopharmaceuticals by End User
8 Asia Pacific
- 8.1 Asia Pacific SPECT Radiopharmaceuticals by Countries
- 8.1.1 Asia Pacific SPECT Radiopharmaceuticals Sales by Countries
- 8.1.2 Asia Pacific SPECT Radiopharmaceuticals Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific SPECT Radiopharmaceuticals by Product
- 8.3 Asia Pacific SPECT Radiopharmaceuticals by End User
9 Central & South America
- 9.1 Central & South America SPECT Radiopharmaceuticals by Countries
- 9.1.1 Central & South America SPECT Radiopharmaceuticals Sales by Countries
- 9.1.2 Central & South America SPECT Radiopharmaceuticals Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America SPECT Radiopharmaceuticals by Product
- 9.3 Central & South America SPECT Radiopharmaceuticals by End User
10 Middle East and Africa
- 10.1 Middle East and Africa SPECT Radiopharmaceuticals by Countries
- 10.1.1 Middle East and Africa SPECT Radiopharmaceuticals Sales by Countries
- 10.1.2 Middle East and Africa SPECT Radiopharmaceuticals Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa SPECT Radiopharmaceuticals by Product
- 10.3 Middle East and Africa SPECT Radiopharmaceuticals by End User
11 Company Profiles
- 11.1 GE Healthcare
- 11.1.1 GE Healthcare Company Details
- 11.1.2 Company Business Overview
- 11.1.3 GE Healthcare SPECT Radiopharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 GE Healthcare SPECT Radiopharmaceuticals Products Offered
- 11.1.5 GE Healthcare Recent Development
- 11.2 Cardinal Health
- 11.2.1 Cardinal Health Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Cardinal Health SPECT Radiopharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Cardinal Health SPECT Radiopharmaceuticals Products Offered
- 11.2.5 Cardinal Health Recent Development
- 11.3 Lantheus Medical Imaging
- 11.3.1 Lantheus Medical Imaging Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Lantheus Medical Imaging SPECT Radiopharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Lantheus Medical Imaging SPECT Radiopharmaceuticals Products Offered
- 11.3.5 Lantheus Medical Imaging Recent Development
- 11.4 Bracco Imaging
- 11.4.1 Bracco Imaging Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Bracco Imaging SPECT Radiopharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Bracco Imaging SPECT Radiopharmaceuticals Products Offered
- 11.4.5 Bracco Imaging Recent Development
- 11.5 Eczacibasi-Monrol Nuclear Products
- 11.5.1 Eczacibasi-Monrol Nuclear Products Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Eczacibasi-Monrol Nuclear Products SPECT Radiopharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Eczacibasi-Monrol Nuclear Products SPECT Radiopharmaceuticals Products Offered
- 11.5.5 Eczacibasi-Monrol Nuclear Products Recent Development
- 11.6 IBA Molecular Imaging
- 11.6.1 IBA Molecular Imaging Company Details
- 11.6.2 Company Business Overview
- 11.6.3 IBA Molecular Imaging SPECT Radiopharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 IBA Molecular Imaging SPECT Radiopharmaceuticals Products Offered
- 11.6.5 IBA Molecular Imaging Recent Development
- 11.7 Jubilant Life Sciences
- 11.7.1 Jubilant Life Sciences Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Jubilant Life Sciences SPECT Radiopharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Jubilant Life Sciences SPECT Radiopharmaceuticals Products Offered
- 11.7.5 Jubilant Life Sciences Recent Development
12 Future Forecast
- 12.1 SPECT Radiopharmaceuticals Market Forecast by Regions
- 12.1.1 Global SPECT Radiopharmaceuticals Sales Forecast by Regions 2019-2025
- 12.1.2 Global SPECT Radiopharmaceuticals Revenue Forecast by Regions 2019-2025
- 12.2 SPECT Radiopharmaceuticals Market Forecast by Product
- 12.2.1 Global SPECT Radiopharmaceuticals Sales Forecast by Product 2019-2025
- 12.2.2 Global SPECT Radiopharmaceuticals Revenue Forecast by Product 2019-2025
- 12.3 SPECT Radiopharmaceuticals Market Forecast by End User
- 12.4 North America SPECT Radiopharmaceuticals Forecast
- 12.5 Europe SPECT Radiopharmaceuticals Forecast
- 12.6 Asia Pacific SPECT Radiopharmaceuticals Forecast
- 12.7 Central & South America SPECT Radiopharmaceuticals Forecast
- 12.8 Middle East and Africa SPECT Radiopharmaceuticals Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 SPECT Radiopharmaceuticals Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on SPECT Radiopharmaceuticals . Industry analysis & Market Report on SPECT Radiopharmaceuticals is a syndicated market report, published as Global SPECT Radiopharmaceuticals Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of SPECT Radiopharmaceuticals market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
